Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Gustavo Cornejo
Coordinator, Regulatory
Senior VP Health Sciences
Overview
Research
More
Collaboration
(47)
Franz Rischard
Mutual work: 5 Proposals﹒2 Grants
Collaboration Details
David Labiner
Mutual work: 1 Grant﹒5 Proposals
Collaboration Details
Scott Sherman
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
C. Kent Kwoh
Mutual work: 2 Proposals
Collaboration Details
Rachna Shroff
Mutual work: 5 Grants﹒5 Proposals
Collaboration Details
Page 1 of 10
Previous page
Next page
Grants
(40)
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have
Active
·
2024
·
$0 / $964K
·
External
undefined (CD)
clinical trials,
dermatology,
immunology,
inflammatory diseases,
pharmacology
Study to Evaluate Safety, Efficacy and Tolerability of ABBV-950 for the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
Active
·
2024
·
$0 / $822.1K
·
External
undefined (CD)
stroke rehabilitation,
spasticity treatment,
drug safety,
efficacy evaluation,
tolerability assessment
A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hyp
Active
·
2024
·
$0 / $555.7K
·
External
undefined (CD)
clinical trials,
pulmonary arterial hypertension,
drug efficacy,
safety evaluation
A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke Who Ar
Active
·
2024
·
$0 / $470.3K
·
External
undefined (CD)
stroke,
clinical trial,
medication,
safety,
efficacy
Protocol Title: A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)
Active
·
2024
·
$0 / $370.5K
·
External
undefined (CD)
stroke,
drug efficacy,
safety evaluation,
clinical trial,
ischemic stroke
Page 1 of 8
Previous page
Next page